Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Molecular Pharmacology|June 20, 2003
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of bindingRachel Davis-Taber, Eduardo J Molinari, Robert J Altenbach, et al.The Journal of Pharmacology and Experimental Therapeutics|July 13, 2007
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivoDaniel B Timmermann, Jens Halvard Grønlien, Kathy L Kohlhaas, et al.Journal of Medicinal Chemistry|December 13, 2006
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel openerRobert J Altenbach, Michael E Brune, Steven A Buckner, et al.Journal of Biomolecular Screening|November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonistsJun Chen, Marc R Lake, Reza S Sabet, et al.Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.Journal of the American Society of Nephrology : JASN|August 23, 2017
Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody ApproachSteve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.British Journal of Pharmacology|August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterizationMurali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.CNS Drug Reviews|June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disordersLynne E Rueter, David J Anderson, Clark A Briggs, et al.Pageof 11